cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Repare Therapeutics Inc
8 own
8 watching
Current Price
$12.45
$-0.38
(-2.96%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
522.42M
52-Week High
52-Week High
18.68
52-Week Low
52-Week Low
8.065
Average Volume
Average Volume
0.15M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization522.42M
icon52-Week High18.68
icon52-Week Low8.065
iconAverage Volume0.15M
iconDividend Yield--
iconP/E Ratio--
What does the Repare Therapeutics Inc do?
N/A
Read More
How much money does Repare Therapeutics Inc make?
News & Events about Repare Therapeutics Inc.
Business Wire
1day ago
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Repare Therapeutics Inc. (Repare or the Company) (NASDAQ: RPTX). Investors who purchased Repare securities are encouraged to obtain additional information and assist the...
Zolmax
2days ago
Morgan Stanley cut shares of Repare Therapeutics (NASDAQ:RPTX Get Rating) from an overweight rating to an equal weight rating in a report released on Friday, MarketBeat reports. The firm currently has $15.00 price objective on the stock, down from their previous price objective of $28.00. A number ...
Business Wire
21days ago
Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that the Company has received an approximately $1.5 million (200 million) research service payment from Ono Pharmaceutical Co., Ltd. (Ono). The payment reflects...
Market News Video
4 months ago
In trading on Tuesday, shares of Repare Therapeutics Inc (RPTX) crossed above their 200 day moving average of 13.60, changing hands as high as 13.69 per share. Repare Therapeutics Inc shares are currently trading up about 7.2% on the day...
Ticker Report
8 months ago
Zacks Investment Research upgraded shares of Repare Therapeutics (NASDAQ:RPTX Get Rating) from a sell rating to a hold rating in a research note released on Thursday, Zacks.com reports. According to Zacks, Repare Therapeutics Inc. is an oncology company. It utilizes genome-wide, ...
Frequently Asked Questions
Frequently Asked Questions
What is Repare Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Repare Therapeutics Inc shares?
plus_minus_icon
How can I buy Repare Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Repare Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Repare Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Repare Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Repare Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Repare Therapeutics Inc?
plus_minus_icon
What percentage is Repare Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Repare Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$12.45
$-0.38
(-2.96%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00